agilon health (NYSE:AGL) Trading Down 6.6% – Here’s Why

agilon health, inc. (NYSE:AGLGet Free Report)’s share price traded down 6.6% on Friday . The company traded as low as $3.11 and last traded at $3.13. 1,039,670 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 5,475,114 shares. The stock had previously closed at $3.35.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Royal Bank of Canada raised their price target on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Stifel Nicolaus raised their price target on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday. Finally, Sanford C. Bernstein raised their price target on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $3.95.

Read Our Latest Research Report on AGL

agilon health Price Performance

The stock’s fifty day moving average price is $2.96 and its 200-day moving average price is $3.01. The firm has a market cap of $1.29 billion, a price-to-earnings ratio of -3.32 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Transactions at agilon health

In other news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karen Mcloughlin purchased 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 77,500 shares of company stock worth $169,600 in the last 90 days. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in agilon health by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after purchasing an additional 272,787 shares during the last quarter. Capital International Investors increased its holdings in agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the last quarter. State Street Corp increased its holdings in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Millennium Management LLC increased its holdings in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares during the last quarter.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.